E2F1 and acute myeloid leukemia: Recently Pulikkan et al. demonstrated that miR-223 targets and inhibits E2F1 which binds to the miR-223 promoter in AML blast cells and inhibits miR-223 transcription, generating negative feedback loop between these two molecules [46].